Solvay's stock shows a remarkable increase of 4.19% to 27.88 euros, surpassing its previous high of 27.96 euros set on January 15th. The Belgian chemical company is benefiting from a sustained upward momentum, with a gain of nearly 11% over the week. This performance occurs in a supportive market environment for the specialty chemicals sector.
Solvay's development demonstrates a significant improvement in its technical setup. The breakthrough of the resistance level at 27.52 euros now opens up room for progression for the Brussels-based group. The RSI, established at 61 points, signals positive momentum without indicating an overbought situation, leaving room for appreciation. The moving averages confirm this renewed investor interest. The stock price moves above its 50-day average, set at 26.74 euros, indicating a short-term trend reversal. This setup is also observed with the upper Bollinger band, close to the current level at 27.84 euros, showing increased but controlled volatility. The support identified at 24.80 euros provides a protection zone in case of a temporary pullback.
Earnings Report Anticipation
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Operators will closely monitor the publication of the annual results for 2025 scheduled for February 24th. This event will occur in a context where the group, following its split with Syensqo at the end of 2023, continues its strategy of focusing on its sodium carbonate and hydrogen peroxide activities. The first quarter of 2026 will be revealed on May 7th, just before the general assembly scheduled for May 12th. Over a year, Solvay's stock still shows a decline of 8.71%, reflecting ongoing concerns about the valuation of the new business perimeter. However, the rebound of 4.66% over three months suggests a gradual restoration of investor confidence. The negative beta of -0.04 indicates a low correlation with general market movements, giving the stock a defensive profile in the current environment.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
